Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Arch Med Res ; 29(3): 235-40, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-9775457

RESUMO

BACKGROUND: Genotoxicity of antibiotics has not been well evaluated, and there is not much information on the genetic risk of quinolone drugs, even though they are widely used as alternative choice drugs in urinary infections. METHODS: Pipemidic acid and norfloxacin were tested for their capacity to induce point mutations using the Ames test and DNA damage on Escherichia coli PolA-/PolA+. RESULTS: At non-toxic doses, all of the drugs studied were negative on the E. coli PolA-/PolA+ test with or without in vitro metabolic activation with induced arochlor 1254 rat liver (S9). They did not produce frameshift mutations in TA98, or base-pair substitutions in S. typhimurium hisG46 strains TA100, or UTH8414. Norfloxacin and its induced metabolites in vitro with S9 rat liver were mutagenic to hisG48 strains TA102 and TA104, both of which detect oxidative chemicals. Pipemidic acid induced mutations in S. typhimurium hisG48 strains only when they had an efficient DNA excision repair system. CONCLUSIONS: These results suggest that the risk of oxygen-free radical generation from quinolones should be considered.


Assuntos
Norfloxacino/toxicidade , Ácido Pipemídico/toxicidade , Animais , Dano ao DNA , Escherichia coli/efeitos dos fármacos , Escherichia coli/genética , Mutação da Fase de Leitura/efeitos dos fármacos , Testes de Mutagenicidade , Mutação Puntual/efeitos dos fármacos , Poli A , Ratos , Salmonella typhimurium
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA